ZoomInfo Appoints Katie Rooney to Board

By Tamara Parker • Friday, January 17 15:41 • Permanent Link

ZoomInfo (NASDAQ: ZI) has appointed Katie Rooney to its board of directors, effective February 1, 2025. Rooney brings over 20 years of experience in finance, operations, strategy, and corporate development with multi-billion dollar enterprises. She was recently named Chief Financial Officer at Maven, the world's largest virtual health platform for women and families.

With Rooney's appointment, ZoomInfo's board of directors will comprise 10 directors, nine of whom are independent.

Rooney's appointment comes at an exciting time for ZoomInfo, with disciplined investments in product and customer success paying off. The company has a clear opportunity to drive consistent growth, continued strong free cash flow generation, and outsized returns for shareholders going forward.

ZoomInfo is a recognized leader in data privacy, with industry-leading GDPR and CCPA compliance and numerous data security and privacy certifications.

ZoomInfo (NASDAQ: ZI) is the go-to-market intelligence platform that empowers businesses to grow faster with AI-ready insights, trusted data, and advanced automation. Its solutions provide more than 35,000 companies worldwide with a complete view of their customers, making every seller their best seller. Today the company's shares have moved -0.6% to a price of $10.12. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.